Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas. - Wikidata - awgldk - TriplyDB

Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.

Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.

http://www.wikidata.org/entity/Q34607838

about

Targeted therapies in sarcomas: challenging the challenge A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue Sarcoma Pazopanib in the management of advanced soft tissue sarcomas UK guidelines for the management of bone sarcomas Giant-cell tumor of bone: treatment options and role of denosumab Modeling human endothelial cell transformation in vascular neoplasias Pazopanib, a new therapy for metastatic soft tissue sarcoma A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biology Addition of Everolimus Post VEGFR Inhibition Treatment Failure in Advanced Sarcoma Patients Who Previously Benefited from VEGFR Inhibition: A Case Series Systemic therapy options for unresectable and metastatic chordomas.The evolution of systemic therapy in sarcoma.Phase II study on lapatinib in advanced EGFR-positive chordoma.Multidisciplinary approach of lumbo-sacral chordoma: From oncological treatment to reconstructive surgery.A unique case of distant skin metastasis from chondroid chordoma Systemic therapy for selected skull base sarcomas: Chondrosarcoma, chordoma, giant cell tumour and solitary fibrous tumour/hemangiopericytoma.Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case series Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group.Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study.Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma.Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study.Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumours Clinical management of secondary angiosarcoma after breast conservation therapy Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.Solitary fibrous tumour of the pleura: A case report.Combining targeted agents with modern radiotherapy in soft tissue sarcomas.Pazopanib for the treatment of soft-tissue sarcoma.Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.Emerging therapies for adult soft tissue sarcoma.Emerging therapeutic targets for synovial sarcoma.A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma.The off-label use of targeted therapies in sarcomas: the OUTC'S program Targeting the tumor microenvironment: focus on angiogenesis.A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies.Targeted therapy in sarcomas other than GIST tumors Efficacy of Tie2 receptor antagonism in angiosarcoma Sunitinib for patients with locally advanced or distantly metastatic dermatofibrosarcoma protuberans but resistant to imatinib.Systemic therapy for advanced soft tissue sarcomas: highlighting novel therapies and treatment approaches Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new.

P2860

Q21285014-4B163B7D-CB2F-40FE-BCB9-A1D0BF75B831 Q26741817-42DB0003-0F85-4240-B2EE-D02E037FB9E7 Q26746205-A1D00A20-4085-4CBF-81C4-4B35D2C61B94 Q26752425-CF7EDAD4-6FC5-4B35-9633-23ED40458557 Q26800332-3F863C8E-3856-42A6-BEF2-6358A23C42D8 Q26860203-B1CD62A5-6DAA-4FD3-B203-F1CF2A610AC9 Q28287163-BABF08F4-6C9A-424E-B495-9E8CEBB94C67 Q28534867-11324DA1-24B7-4587-B1BF-12A3218EA4DF Q28550228-DC0426FC-BFEA-4557-87A7-0EDD6524801C Q33274146-29C97E76-178F-4901-A390-C58329FC075B Q33274710-157019BD-7486-41AB-96F4-49F26B539BAF Q33274760-D003F51E-80DD-47B4-BB50-8ED1FC41EC8A Q33275786-FF8A3857-9324-4716-82CC-C0AE63BB6A61 Q33275970-86B30932-FAAF-41E4-B4C2-0650BB46ECA4 Q33276109-A16BAD23-B4B7-4568-9AB5-7E3EE0E6FF01 Q33276267-591F57DE-41A2-4037-9E7F-040EE2EEBD1E Q33276384-FDBB5E34-EF8A-4BE6-AD2B-773D1A613DC6 Q33395853-E17288A2-7C32-490F-8EF1-717C2E7566F4 Q33396181-46E8E35B-78AB-4960-A5EC-1897F3F4D047 Q33408668-72F21571-D0D5-48D4-B780-0F88022428B2 Q33416940-0D0DDEA6-36B2-4171-9296-5044EB38D64B Q33430673-BEE3CAF5-0F8E-4B9F-A898-8B44ADCB1181 Q33433105-36C22810-3209-4A75-8D7A-0C7C8C2C174B Q33751719-14EB6346-9E74-4347-A8AF-25514E5EF0C0 Q33910609-51BE9221-1B66-4F7C-986D-B3C3D4F4767B Q33975264-B3B960F3-C8A2-4196-A742-3A8125148FE4 Q34396047-95D2410D-050C-4A75-AC2B-B7A5353FE421 Q34645938-8F16731D-64C9-4CF1-8F4D-AB8FEBCE5278 Q34652972-7B77FFD8-DA93-4B10-A7B2-22AD196464EB Q34659806-48A81F7A-5614-40D1-8F3E-EEA240DB710B Q34660607-C1B8D453-6A5D-43CC-B1B3-778FC017773B Q34687036-77008E2F-8A4D-4755-9630-2D75A2798056 Q34897996-0DF13598-E83C-44B7-86A4-2A185501DD33 Q35184806-DC603053-EC69-4DF1-9C6F-283F996CDA65 Q35207344-2C5E4966-2E75-4842-BEE7-72F119900D39 Q35622367-A0B3F74B-C1C4-4198-8FEB-D3E06EB53A6F Q35836039-5125DB0F-5233-4592-A4D1-799CDFCC7CC8 Q35871185-41B73FB3-3F2B-4876-BF74-94D8F38253BF Q36144210-C0697F6C-071A-4FDC-B2F1-223177E2598C Q36389964-416B03D0-4ABC-4857-A890-55ABA6D2DD76

P2860

Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.

http://www.wikidata.org/entity/Q34607838

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Multicenter phase II trial of ...... stinal stromal tumor sarcomas.

@ast

Multicenter phase II trial of ...... stinal stromal tumor sarcomas.

@en

Multicenter phase II trial of ...... stinal stromal tumor sarcomas.

@nl

type

label

Multicenter phase II trial of ...... stinal stromal tumor sarcomas.

@ast

Multicenter phase II trial of ...... stinal stromal tumor sarcomas.

@en

Multicenter phase II trial of ...... stinal stromal tumor sarcomas.

@nl

prefLabel

Multicenter phase II trial of ...... stinal stromal tumor sarcomas.

@ast

Multicenter phase II trial of ...... stinal stromal tumor sarcomas.

@en

Multicenter phase II trial of ...... stinal stromal tumor sarcomas.

@nl

P1433

Q34607838-F2F19A89-9720-4672-8C4B-3A5B31CE3EE9

P1476

Q34607838-4BE974D9-4F76-4494-93D0-C9058CC6BF2C

P2093

Q34607838-5BC4AB96-A9CB-4171-A108-DBEFC1C7E633

Q34607838-62D0BE15-C853-4D02-A3FB-E07DE499D3A6

Q34607838-7679FC47-E2F1-4706-A22F-692E745A1AB3

Q34607838-8306C393-A6A2-4605-9B55-35A7C1152E09

Q34607838-9AE6A8F5-3C91-4C85-8327-7C21A2A842B3

Q34607838-9EDA2C37-A053-4369-B81D-A58D6899B236

Q34607838-B9389A8F-E1CB-4169-8D29-4A8CC1408C85

Q34607838-BE5FAB71-7654-4E43-8B66-95985FC59ECF

Q34607838-C713CDBC-9013-46A9-939F-3392924B89B4

Q34607838-CE040C57-6E5A-453A-829A-71687B505A60

P2860

Q34607838-02689F87-F829-4E05-8EB8-D9B056EDB208

Q34607838-1CB94101-6CA5-4EBC-90A7-599272677FA5

Q34607838-215365B1-7D6F-4E4A-908F-C0B77D09E032

Q34607838-2FC91798-969F-4714-AAF5-EFD7E7997120

Q34607838-3B55AEA3-B9E8-430F-8F4F-D9DCD1079AA3

Q34607838-3BC42B45-4BC6-4B0C-BEEC-30666D489396

Q34607838-3C7E554B-B8A2-446C-B545-FABC7EDCF30D

Q34607838-42312D01-1B9B-4C96-B715-07490A861896

Q34607838-423F57A3-C5EF-429D-A560-25B419BA7D71

Q34607838-442E3143-AEDA-438C-87AE-1142043856B2

P304

Q34607838-6CF21E9F-147D-4D61-B3DC-89C1C0FFD7F6

P31

Q34607838-9F497B98-762A-4025-A600-546AC0FBC4BE

P356

Q34607838-4545C329-114B-4309-AB4C-E7B59204C5FF

P407

Q34607838-024CAF87-3645-4EF8-8C9D-6A7889A5F62D

P433

Q34607838-37CC1D57-A983-49F2-B53A-80D6D9DA651B

P478

Q34607838-75BEA2A5-A220-4170-940A-5E88A68F4A3B

P50

Q34607838-B675A135-2D93-4896-BD64-689948912719

Q34607838-CBFF9AF1-2338-40DD-BBF4-E816A68EDC1B

P577

Q34607838-5FDA69E8-91A3-423F-8878-A6D70CB19E26

P5875

Q34607838-4BEA656D-37FD-4A21-82A5-56C58284151C

P698

Q34607838-2A3F286A-8274-4710-9C6F-40999F3426D7

P921

Q34607838-45719435-8468-4FB1-A74C-32F26117EA5A

Q34607838-C3DE1DBA-9F62-4D48-9465-89B0AE85053D

P932

Q34607838-70B766BE-A3D4-408E-8C96-2D5AC3672704

P356

JCO.2008.20.9890

P1433

Journal of Clinical Oncology

P1476

Multicenter phase II trial of ...... estinal stromal tumor sarcomas

@en

P2093

Andrew J Wagner

http://www.w3.org/2001/XMLSchema#string

Annick D Van den Abbeele

http://www.w3.org/2001/XMLSchema#string

David C Harmon

http://www.w3.org/2001/XMLSchema#string

David R D'Adamo

http://www.w3.org/2001/XMLSchema#string

Gary K Schwartz

http://www.w3.org/2001/XMLSchema#string

Gauri Bhuchar

http://www.w3.org/2001/XMLSchema#string

George D Demetri

http://www.w3.org/2001/XMLSchema#string

James E Butrynski

http://www.w3.org/2001/XMLSchema#string

Jeffrey Morgan

http://www.w3.org/2001/XMLSchema#string

Margaret M O'Mara

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Imatinib mesylate in chordoma

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas.

Pleural malignant solitary fibrous tumor with sarcomatous overgrowth showing PDGFRbeta mutation.

Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects.

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Signal transduction pathways in sarcoma as targets for therapeutic intervention.

P304

3154-3160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2008.20.9890

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24436245

http://www.w3.org/2001/XMLSchema#string

P698

19451429

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

multicenter trial

P932

2716937

http://www.w3.org/2001/XMLSchema#string